The substitution F447L is adaptive for J4_S52-HVR1, while it decreases infectivity of parental J4 and J4_ΔHVR1 HCVcc. by Christina Holmboe Olesen (11154333)

Cardiac-specific p38γ/δ^act overexpression decreases cardiac glycogen storage and lipid accumulation. by Ayelén M. Santamans (5487941)

LncRNA <i>C5orf64</i> polymorphisms (rs12518552 and rs2950218) decreases pulmonary tuberculosis susceptibility by Shilin Xu (1884217)

S1 Data - by Francois Kiemde (5369657)

“…Venous blood was collected at scheduled visit: Visit 1 (V1; 16–20 weeks of amenorrhea), Visit 2 (V2; 28 ±1 weeks of pregnancy), Visit 3 (V3; 32 ±1 weeks of pregnancy), Visit4 (V4; delivery) and Visit5 (V5; 6–7 weeks after delivery). …”

Characteristic of study population. by Francois Kiemde (5369657)

“…Venous blood was collected at scheduled visit: Visit 1 (V1; 16–20 weeks of amenorrhea), Visit 2 (V2; 28 ±1 weeks of pregnancy), Visit 3 (V3; 32 ±1 weeks of pregnancy), Visit4 (V4; delivery) and Visit5 (V5; 6–7 weeks after delivery). …”

TUNEL staining of testis tissues. by Cao Wang (1500691)

Subjects:

Morphological changes in the testis and epididymis. by Cao Wang (1500691)

Subjects:

Raw images of gels and blots. by Cao Wang (1500691)

Subjects:

Pregnancy rate of female rats in each group. by Cao Wang (1500691)

Subjects:

Oxidative stress (OS) responses in the testis tissues. by Cao Wang (1500691)

Subjects:

Ultrastructure of mitochondria in germ cells. by Cao Wang (1500691)

Subjects:

Dynamics of cortisol levels measured in pregnant women during pregnancy determined at different ANC visits. by Francois Kiemde (5369657)

“…In both group, cortisol concentration increased in a sawtooth pattern during pregnancy with peaks at V2(28^th±1 week) and V4 32^th ±1 week), before decreasing at V5 which is part of post-partum.…”

Decreasing HIV viral loads across subdistricts in KwaZulu-Natal province, South Africa, between 2018 and 2022. by Lilishia Gounder (15240167)

Subjects:

Fig 5 - by Zixiang Wang (7548716)

pDNA-PK levels are decreased in absence of cGAS. by Elona Gusho (4688170)

S5 Dataset - by Devon England (21262225)

Efficacy of an herbal compound in decreasing steatosis and transaminase activities in non-alcoholic fatty liver disease: A randomized clinical trial by Seyyed Abbas Zojaji (5208589)

“…<div><p>Abstract Hepatoprotective effects of many herbal agents have been reported in animal studies and clinical trials. In this study, five hepatoprotective plants with potent antioxidant, anti-inflammatory, and hypolipidemic effects were chosen to prepare a polyherbal compound for managing NAFLD. …”

Fig 5 - by Anwesha Das (13449995)

<i>Aspergillus flavus</i> mRNA expression (a) <i>aflD</i> and (c) <i>aflR</i> and phylogenetic analysis of (b) <i>aflD</i> and (d) <i>aflR</i> after exposure to 50 mg/mL of <i>U. e... by Martha Cebile Jobe (21175426)

Subjects:

Quantification and accuracy of average VAF. by Lizhi Yu (12476136)

Subjects: